Western University of Health Sciences
Pomona, California, 91766, United States
NCT Number: NCT05252871
This clinical trial investigates the differences between three different progressive addition lens designs. It is a non-invasive double-masked randomized clinical investigation. For this study, 80 participants will be recruited.
Looking for future studies?
Notify Me45 year–70 year
All sexes
Interventional
Not applicable
Pomona, California, 91766, United States
The purpose of the study is to evaluate the preference, adaptability, and visual performance of three progressive lens designs. The difference in these lens designs is a variation of zone sizes for intermediate and near vision. The clinical trial helps manufacturers and eye care practitioners to give detailed suggestions to patients. Study participants will be experienced progressive addition lens wearers, which will be recruited by advertisements, by email, and with direct person-to-person solicitation. The study will be conducted at the Eye Care Institute at the Patient Care Center Western University of Health Sciences, Pomona, CA, 91766. For each participant, the study is completed in around two months and requires three separate visits.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will be wearing three different PAL designs with different geometries of the optical progression.
Time frame: Entire study duration (approx. 4 weeks)
Evaluate the adaptation to progressive lens designs through a "Satisfaction questionnaire" after 1 week of use of each of the 3 progressive addition lenses.
Scale titles: Visual Quality Scale: A 5-point scale from a minimum value of 1 to a maximum score of 5. Higher scores mean better outcomes.
Time frame: Directly after receiving the lenses (approx. 15 minutes)
Evaluate the immediate preference for progressive lens designs through a "Satisfaction questionnaire" directly after receiving the 3 progressive addition lenses.
Scale titles: Visual Quality Scale: A 5-point scale from a minimum value of 1 to a maximum score of 5. Higher scores mean better outcomes.
Time frame: Entire study duration (approx. 4 weeks)
Evaluate the final preference of progressive lens designs after wearing each of the 3 PALs for one week.
Scale title: Preference of Progressive Addition Lenses Scale: "Pair 1", "Pair 2, "Pair 3"
Western University of Health Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07723716
Eye Diseases, Presbyopia
Seoul, South Korea
View Trial DetailsNCT05646719
Eye Diseases, Presbyopia
Phoenix, Arizona, United States
View Trial DetailsNCT07076160
Eye Diseases, Presbyopia
Jacksonville, Florida, United States
View Trial DetailsNCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial Details